Hemorheological disturbances in patients with chronic cerebrovascular diseases

L. Szapary, B. Horvath, Zs Marton, T. Alexy, N. Demeter, M. Szots, A. Klabuzai, G. Kesmarky, I. Juricskay, V. Gaal, J. Czopf, K. Toth

Research output: Contribution to journalArticlepeer-review

45 Scopus citations


Hemorheological disturbances may occur in more than 40% of patients with ischemic cerebrovascular diseases. In this study the changes of rheological factors - hematocrit, plasma fibrinogen concentration, whole blood and plasma viscosity, red blood cell aggregation and deformability were investigated in 297 patients (173 males, 124 females, mean age 60 ± 11 years) with transient ischemic attack or chronic phase (>3 months after onset) ischemic stroke, and in 73 healthy volunteers (35 males, 38 females, mean age 38 ± 7 years). Hematocrit, plasma and whole blood viscosity were significantly (p < 0.0001) elevated in cerebrovascular patients compared to controls. Plasma fibrinogen concentration (p < 0.001), red blood cell aggregation (p < 0.05) and deformability (p < 0.01) were also impaired in stroke patients. Hemorheological disturbances were dominant in stroke patients with diabetes, hyperlipidemia and smoking habits. Hematocrit, plasma viscosity and red blood cell aggregation showed a significant (p < 0.025-0.001) correlation with the severity of carotid artery stenosis. We could not find any characteristic distribution of rheological parameters among the three subtypes of brain ischemia. Our results show that all of the measured rheological parameters are significantly impaired in chronic ischemic cerebrovascular disorders, especially in diabetic, smoking and alcoholic patients. They correlate with the severity of the carotid artery stenosis, but there is no association with the type of ischemic stroke.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalClinical hemorheology and microcirculation
Issue number1
StatePublished - Aug 30 2004


Dive into the research topics of 'Hemorheological disturbances in patients with chronic cerebrovascular diseases'. Together they form a unique fingerprint.

Cite this